Your Health. Your Goals. Your Journey.
At NuVitalis, we believe medical weight management begins with understanding you. Our approach emphasizes individualized consultations, thoughtful treatment planning, and education about available medical options.
Explore how prescription-based weight management therapies work, what eligibility and safety considerations matter, and how a qualified healthcare professional can help determine an appropriate path forward.
BOOK A WEIGHT LOSS CONSULTATION
How Hormonal Signaling Influences Appetite & Metabolism
Your body naturally produces hormones that help regulate hunger, digestion, and blood sugar. Two of these hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), play important roles in metabolic signaling.
Medications that activate GLP-1 receptors can help reduce appetite and increase feelings of fullness. Some medications also activate GIP receptors, providing an additional mechanism involved in glucose regulation and metabolic function.
These medications are not appropriate for everyone. Their use requires consideration of medical history, treatment goals, potential adverse effects, and ongoing clinical monitoring.


Exploring Established Therapies & Emerging Research
Weight management medications are not all the same. Different compounds act on distinct hormonal pathways, and their clinical evidence, regulatory status, and safety considerations vary.
Understanding these differences is an important part of making informed decisions with a qualified healthcare professional. Treatment eligibility and medication selection should always be based on an individualized medical assessment.
GLP-1 Receptor Agonist • Appetite & Metabolic Regulation
Semaglutide is a medication that mimics the activity of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone involved in appetite regulation, digestion, and blood sugar control.
FDA-approved semaglutide medications have demonstrated clinically meaningful weight reduction in eligible patients when combined with dietary changes and physical activity. Individual responses vary, and treatment requires appropriate medical supervision.
Activates GLP-1 receptors, helping regulate appetite, increase feelings of fullness, and support glucose-dependent insulin release.
A medical assessment should review eligibility, gastrointestinal side effects, contraindications, medication interactions, and follow-up monitoring.
Compounded semaglutide preparations are not FDA-approved. They have not undergone FDA review for safety, effectiveness, or quality and may only be prescribed and compounded when applicable legal requirements are met.
Dual GIP/GLP-1 Receptor Agonist • Appetite & Metabolic Regulation
Tirzepatide is a medication that activates two hormone receptors involved in metabolic regulation: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1).
FDA-approved tirzepatide products have demonstrated substantial weight reduction in eligible patients when combined with reduced-calorie nutrition and increased physical activity. Treatment response varies, and medical supervision is essential.
Activates both GIP and GLP-1 receptors, influencing appetite, fullness, and glucose-dependent insulin secretion.
A medical assessment should review eligibility, gastrointestinal side effects, contraindications, medication interactions, and ongoing monitoring.
Compounded tirzepatide is not FDA-approved and has not undergone FDA review for safety, effectiveness, or quality. Compounding and prescribing must meet applicable legal requirements.
At NuVitalis, medical weight management begins with understanding your individual needs. Our consultation process emphasizes health history, treatment eligibility, informed decision-making, and ongoing support.
Discuss your health goals, medical history, current medications, and previous weight management experiences.
A qualified prescribing clinician assesses treatment eligibility, potential contraindications, and whether additional testing is appropriate.
If medically appropriate, a personalized plan may include nutrition, physical activity, behavioral strategies, and prescription treatment options.
Regular follow-up helps evaluate treatment response, review side effects, and determine whether adjustments are needed.
YOUR HEALTH COMES FIRST
Prescription weight management is not a one-size-fits-all solution. Eligibility depends on your health history, weight-related risk factors, treatment goals, and the specific medication being considered. A qualified prescribing clinician can help determine whether medical treatment is appropriate.
Certain FDA-approved weight management medications are intended for adults with obesity, or those who are overweight with a weight-related medical condition. Eligibility criteria vary by medication.
Your clinician should review your medical history, current medications, pregnancy plans, relevant contraindications, and potential side effects before recommending treatment.
Appropriate care includes nutrition and activity guidance, assessment of treatment response, monitoring for adverse effects, and adjustments when clinically indicated.
GLP-1–based medications can cause nausea, vomiting, diarrhea, constipation, and other adverse effects. Certain products carry boxed warnings and have important contraindications, including personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). A medical evaluation is essential before starting treatment.
Take the first step toward understanding your medical weight management options. Schedule a consultation at NuVitalis to discuss your health goals, review treatment eligibility, and explore an individualized approach to your wellness.
BOOK A WEIGHT LOSS CONSULTATION
Treatment recommendations are based on individual medical eligibility and clinical evaluation.